Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Beyfortus
Beyfortus
Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales
BioSpace
Fri, 10/25/24 - 11:22 am
Sanofi
earnings
Beyfortus
Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
Reuters
Fri, 10/4/24 - 09:22 am
Thermo Fisher
FDA
RSV
Beyfortus
Sanofi
AstraZeneca
drug manufacturing
Sanofi readies to meet US demand for RSV antibody
BioPharma Dive
Mon, 09/16/24 - 10:17 pm
Sanofi
AstraZeneca
Beyfortus
RSV
antibodies
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Sanofi
AstraZeneca
Beyfortus
RSV
monoclonal antibodies
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Sanofi
RSV
AstraZeneca
Beyfortus
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
AstraZeneca
Sanofi
Beyfortus
RSV
vaccines
China
Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus
Fierce Pharma
Mon, 11/20/23 - 09:38 pm
Sanofi
AstraZeneca
Senate
CDC
RSV
Beyfortus
drug shortages
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Clinical Trials Arena
Tue, 08/29/23 - 11:23 am
Pfizer
AstraZeneca
Sanofi
Abrysvo
Beyfortus
RSV
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
Stat
Thu, 08/3/23 - 06:34 pm
CDC
RSV
infants
monoclonal antibodies
Sanofi
Beyfortus
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
Fierce Pharma
Tue, 07/18/23 - 10:06 pm
CDC
Sanofi
AstraZeneca
RSV
Beyfortus
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Mon, 07/17/23 - 07:00 pm
Sanofi
AstraZeneca
Beyfortus
nirsevimab
RSV
infants
pediatric
FDA
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
Thu, 06/8/23 - 09:47 pm
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch
Biopharma Reporter
Wed, 04/12/23 - 11:30 am
Sanofi
AstraZeneca
Sobi
Beyfortus
RSV
Sanofi, AstraZeneca win EMA support for RSV drug in babies
BioPharma Dive
Sun, 09/18/22 - 10:22 pm
AstraZeneca
Beyfortus
RSV
Europe
pediatric
infants
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Sanofi
AstraZeneca
Pfizer
GSK
nirsevimab
Beyfortus
RSV